Physician profile
Johnny Hickson
NPI 1528295755
$15,774.00
in general payments reported to CMS, 2019-2025
51 companies · $3,500 in 2025
The $3,500 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,942 · 2020: $1,427 · 2021: $2,298 · 2022: $1,992 · 2023: $2,495 · 2024: $2,119 · 2025: $3,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,313 · Travel and Lodging: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,313.27 |
| Travel and Lodging | $800.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,154.36 | 2019-2025 | Ams 700, General - Erectile Dysfunction, Ams 700 Cxr Rte Kit |
| Procept Biorobotics Corporation | $1,549.54 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $1,483.60 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Abbvie INC. | $1,267.50 | 2019-2025 | |
| Coloplast Corp | $869.53 | 2021-2025 | |
| Pfizer INC. | $762.64 | 2019-2025 | |
| Axonics, INC. | $669.00 | 2020-2024 | Axonics, Bulkamid |
| Janssen Biotech, INC. | $616.16 | 2019-2025 | Erleada, Akeega |
| Myriad Genetic Laboratories, INC. | $479.69 | 2020-2024 | Prolaris |
| Neotract INC. | $438.83 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $384.79 | 2023-2025 | Orgovyx, Gemtesa |
| Clarus Therapeutics INC. | $282.26 | 2021 | |
| Sun Pharmaceutical Industries INC. | $204.54 | 2022-2024 | Yonsa |
| Verity Pharmaceuticals INC. | $195.31 | 2024-2025 | Trelstar |
| Myovant Sciences INC. | $185.65 | 2021-2022 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnny Hickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.